Unknown

Dataset Information

0

Serological Responses to Human Virome Define Clinical Outcomes of Italian Patients Infected with SARS-CoV-2.


ABSTRACT: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the pandemic respiratory infectious disease COVID-19. However, clinical manifestations and outcomes differ significantly among COVID-19 patients, ranging from asymptomatic to extremely severe, and it remains unclear what drives these disparities. Here, we studied 159 hospitalized Italian patients with pneumonia from the NIAID-NCI COVID-19 Consortium using a phage-display method to characterize circulating antibodies binding to 93,904 viral peptides encoded by 1,276 strains of human viruses. SARS-CoV-2 infection was associated with a marked increase in individual's immune memory antibody repertoires linked to trajectories of disease severity from the longitudinal analysis also including anti-spike protein antibodies. By applying a machine-learning-based strategy, we developed a viral exposure signature predictive of COVID-19-related disease severity linked to patient survival. These results provide a basis for understanding the roles of memory B-cell repertoires in COVID-19-related symptoms as well as a predictive tool for monitoring its clinical severity.

SUBMITTER: Wang L 

PROVIDER: S-EPMC7480049 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Serological Responses to Human Virome Define Clinical Outcomes of Italian Patients Infected with SARS-CoV-2.

Wang Limin L   Candia Julián J   Ma Lichun L   Zhao Yongmei Y   Imberti Luisa L   Sottini Alessandra A   Dobbs Kerry K   Lisco Andrea A   Sereti Irini I   Su Helen C HC   Notarangelo Luigi D LD   Wang Xin Wei XW  

medRxiv : the preprint server for health sciences 20200907


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the pandemic respiratory infectious disease COVID-19. However, clinical manifestations and outcomes differ significantly among COVID-19 patients, ranging from asymptomatic to extremely severe, and it remains unclear what drives these disparities. Here, we studied 159 hospitalized Italian patients with pneumonia from the NIAID-NCI COVID-19 Consortium using a phage-display method to characterize circulating antibodies  ...[more]

Similar Datasets

| S-SCDT-10_15252-EMMM_202317580 | biostudies-other
| S-EPMC9298128 | biostudies-literature
| S-SCDT-EMBOJ-2020-106267 | biostudies-other
| S-SCDT-EMM-2021-14122 | biostudies-other
| S-EPMC8402807 | biostudies-literature
| S-BSST1037 | biostudies-other
| S-EPMC9365864 | biostudies-literature
| S-SCDT-10_1038-S44318-024-00061-0 | biostudies-other
2023-05-25 | E-MTAB-13028 | biostudies-arrayexpress
| EMPIAR-10753 | biostudies-other